1. Home
  2. INTS vs ORKT Comparison

INTS vs ORKT Comparison

Compare INTS & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • ORKT
  • Stock Information
  • Founded
  • INTS 2012
  • ORKT 2003
  • Country
  • INTS United States
  • ORKT Singapore
  • Employees
  • INTS N/A
  • ORKT N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • ORKT
  • Sector
  • INTS Health Care
  • ORKT
  • Exchange
  • INTS Nasdaq
  • ORKT NYSE
  • Market Cap
  • INTS 33.4M
  • ORKT 34.7M
  • IPO Year
  • INTS 2023
  • ORKT 2024
  • Fundamental
  • Price
  • INTS $2.11
  • ORKT $1.23
  • Analyst Decision
  • INTS Strong Buy
  • ORKT Strong Buy
  • Analyst Count
  • INTS 3
  • ORKT 1
  • Target Price
  • INTS $8.50
  • ORKT $5.00
  • AVG Volume (30 Days)
  • INTS 33.1K
  • ORKT 7.9M
  • Earning Date
  • INTS 03-13-2025
  • ORKT 10-16-2024
  • Dividend Yield
  • INTS N/A
  • ORKT N/A
  • EPS Growth
  • INTS N/A
  • ORKT N/A
  • EPS
  • INTS N/A
  • ORKT N/A
  • Revenue
  • INTS N/A
  • ORKT $3,904,592.00
  • Revenue This Year
  • INTS N/A
  • ORKT N/A
  • Revenue Next Year
  • INTS N/A
  • ORKT N/A
  • P/E Ratio
  • INTS N/A
  • ORKT N/A
  • Revenue Growth
  • INTS N/A
  • ORKT N/A
  • 52 Week Low
  • INTS $1.50
  • ORKT $0.62
  • 52 Week High
  • INTS $5.94
  • ORKT $8.00
  • Technical
  • Relative Strength Index (RSI)
  • INTS 41.98
  • ORKT N/A
  • Support Level
  • INTS $1.84
  • ORKT N/A
  • Resistance Level
  • INTS $2.53
  • ORKT N/A
  • Average True Range (ATR)
  • INTS 0.32
  • ORKT 0.00
  • MACD
  • INTS -0.02
  • ORKT 0.00
  • Stochastic Oscillator
  • INTS 37.50
  • ORKT 0.00

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

Share on Social Networks: